Skip to main content
JINLING PHARMACEUTICAL CO.,LTD logo

JINLING PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000919 ISIN · CNE0000010W5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,771 across all filing types
Latest filing 2023-06-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000919

About JINLING PHARMACEUTICAL CO.,LTD

https://www.jlyy1999.com

Jinling Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and sale of pharmaceutical products, with a focus on chemical drugs and traditional Chinese medicine preparations. The company’s product portfolio primarily targets cardiovascular and cerebrovascular diseases, anti-tumor treatments, and digestive system health. A prominent product in its lineup is the Mailuoning Injection, utilized for treating various vascular conditions. In addition to its manufacturing operations, the company is involved in the management and operation of medical institutions, integrating clinical services with pharmaceutical production. Its business model emphasizes the synergy between drug development and healthcare service delivery to provide integrated medical solutions.

Recent filings

Filing Released Lang Actions
江苏泰和律师事务所关于金陵药业股份有限公司2023年第二次临时股东大会法律意见书
Regulatory Filings
2023-06-28 Chinese
金陵药业股份有限公司2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 second extraordinary general meeting of shareholders of Jinling Pharmaceutical Co., Ltd. It includes information about the meeting date, attendance, voting procedures, and the election results of the board of directors and supervisors. It also contains a legal opinion confirming the validity of the meeting and voting process. The content focuses on the voting results and changes in the board composition rather than the meeting materials or presentations. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3755 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report publication or a brief notice.
2023-06-28 Chinese
金陵药业股份有限公司关于特定股东减持股份计划届满的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the completion of a specific shareholder's share reduction plan. It details the number of shares reduced, the period of reduction, and compliance with relevant securities laws and regulations. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about a shareholder's transaction in shares, specifically a reduction in holdings by a particular shareholder. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2023-06-26 Chinese
金陵药业关于召开2023年第二次临时股东大会的通知（更正后）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2023 second extraordinary general meeting of shareholders for Jinling Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures, proposals to be voted on (including board and supervisory committee elections), registration details, and proxy forms. There is no financial data or results reported, nor is it a transcript or presentation. The document is clearly an announcement of a shareholders meeting and the related voting process, focusing on board elections and meeting logistics. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than the actual voting results or proxy solicitation materials, it is best classified as a Proxy Solicitation & Information Statement (PSI). The document length and content confirm it is not a brief announcement but a full notice with detailed voting instructions and proxy forms, which aligns with PSI.
2023-06-26 Chinese
金陵药业股份有限公司关于召开2023年第二次临时股东大会通知的更正公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a correction announcement regarding the notice for convening the 2023 second extraordinary general meeting of shareholders of Jinling Pharmaceutical Co., Ltd. It includes corrected details about proposals and voting instructions for the shareholders meeting. There is no financial data, earnings, or report content. It is not a full report but a correction to a meeting notice. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly a Regulatory Filing (RNS). However, since it specifically relates to shareholder meeting proposals and voting instructions, it aligns best with Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting proposals and corrections, not a full report or presentation.
2023-06-26 Chinese
金陵药业关于分公司收到硫酸镁注射液受理通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Jinling Pharmaceutical Co., Ltd. regarding the receipt of a drug registration acceptance notice from the National Medical Products Administration for Magnesium Sulfate Injection. It details the drug's registration application, clinical use, market data, and potential impact on the company. The document is short (889 characters) and serves as an official notification about regulatory acceptance rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is not a report publication announcement since it is not announcing the release of a report but rather a regulatory acceptance notice. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-07 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.